| Health / Medical Topics |
Caricotamide
A synthetic co-substrate that activates the human endogenous enzyme NRH:quinone oxidoreductase 2 (NQO2) with potential chemoadjuvant activity. When caricotamide is administered simultaneously with the prodrug tretazicar, NQO2 converts tretazicar to the bifunctional alkylating agent dinitrobenzamide, which is capable of forming a high degree of DNA interstrand cross-links, resulting in the inhibition of DNA replication and the induction of apoptosis. NQO2 has been found to be over-expressed in cancers such as hepatocellular carcinoma (HCC), colorectal and ovarian cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
Denotes a person having origins in one of the indigenous people of the Caribbean.
A group of islands in the Caribbean Sea. These islands curve southward from the bottom tip of Florida to the Northwest of…
An orally active, synthetic structural analogue of N-acetylglutamate (NAG) and carbamoyl phosphate synthetase 1 (CPS 1) activator, with ammonia lowering activity. NAG,…
A drug used to treat multiple myeloma that has not gotten better with other anticancer drugs. It is also being studied in…
Caregivers provide help to another person in need. The person receiving care may be an adult - often a parent or a…
A person who gives care to people who need help taking care of themselves. Examples include children, the elderly, or patients…
